Island Pharmaceuticals Limited (ASX:ILA)
0.4900
+0.0050 (1.03%)
At close: Mar 11, 2026
Island Pharmaceuticals Revenue
Island Pharmaceuticals had revenue of 40.78K AUD in the half year ending December 31, 2025, a decrease of -95.75%. This brings the company's revenue in the last twelve months to 62.85K, down -84.26% year-over-year. In the fiscal year ending June 30, 2025, Island Pharmaceuticals had annual revenue of 118.91K, down -90.57%.
Revenue (ttm)
62.85K
Revenue Growth
-84.26%
P/S Ratio
2,274.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
142.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 118.91K | -1.14M | -90.57% |
| Jun 30, 2024 | 1.26M | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Botanix Pharmaceuticals | 21.92M |
| Starpharma Holdings | 14.58M |
| Orthocell | 9.33M |
| Dimerix | 7.42M |
| Actinogen Medical | 7.36M |
| Arovella Therapeutics | 3.21M |
| Tetratherix | 2.00M |
| Cynata Therapeutics | 1.69M |